Mesa Laboratories, Inc. (NASDAQ:MLAB) Declares $0.16 Quarterly Dividend

Mesa Laboratories, Inc. (NASDAQ:MLAB) declared a quarterly dividend on Wednesday, October 2nd,Zacks Dividends reports. Investors of record on Friday, November 29th will be given a dividend of 0.16 per share by the medical instruments supplier on Monday, December 16th. This represents a $0.64 annualized dividend and a dividend yield of 0.54%. The ex-dividend date is Friday, November 29th.

Mesa Laboratories has a dividend payout ratio of 6.5% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Mesa Laboratories to earn $8.29 per share next year, which means the company should continue to be able to cover its $0.64 annual dividend with an expected future payout ratio of 7.7%.

Mesa Laboratories Trading Up 1.6 %

NASDAQ MLAB opened at $118.35 on Thursday. The company has a quick ratio of 0.51, a current ratio of 0.70 and a debt-to-equity ratio of 0.65. The firm has a market cap of $642.64 million, a PE ratio of -2.56 and a beta of 0.87. The company has a 50 day moving average price of $120.99 and a 200 day moving average price of $114.50. Mesa Laboratories has a 52 week low of $83.68 and a 52 week high of $141.17.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on MLAB shares. StockNews.com lowered shares of Mesa Laboratories from a “buy” rating to a “hold” rating in a research note on Wednesday, November 13th. Evercore ISI boosted their price objective on shares of Mesa Laboratories from $120.00 to $160.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 1st. Finally, Wells Fargo & Company started coverage on shares of Mesa Laboratories in a research note on Tuesday, August 27th. They set an “underweight” rating and a $120.00 price target on the stock.

Insider Buying and Selling at Mesa Laboratories

In other news, CEO Gary M. Owens sold 2,518 shares of the company’s stock in a transaction on Monday, October 28th. The shares were sold at an average price of $113.62, for a total value of $286,095.16. Following the sale, the chief executive officer now directly owns 45,888 shares of the company’s stock, valued at $5,213,794.56. This represents a 5.20 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Brian David Archbold sold 1,499 shares of the firm’s stock in a transaction on Friday, September 13th. The stock was sold at an average price of $125.00, for a total transaction of $187,375.00. The disclosure for this sale can be found here. Company insiders own 4.40% of the company’s stock.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.